Immobilized Recombinant Human CD19 Protein (ECD, His Tag) (Cat: 11880-H08W1) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti- CD19 Antibody, Human IgG1, the EC50 is 4-15 ng/mL. (Routinely tested) |
Loaded Biotinylated Inebilizumab on SA Biosensor, can bind Recombinant Human CD19 Protein, His Tag, High activity (Cat. No. 11880-H08W1) with an affinity constant of 9.58 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested). |
Immobilized Monoclonal Anti- CD19 Antibody, Human IgG1 at 2 μg/mL (100 μL/well) can bind Recombinant Human CD19 Protein (ECD, His Tag) (Cat: 11880-H08W1), the EC50 is 15-50 ng/mL.(QC tested) |
Inebilizumab captured on Protein A chip can bind Recombinant Human CD19 Protein, His Tag (Cat. No. 11880-H08W1) with an affinity constant of 0.498 nM as determined in an SPR assay (Biacore T200) (Routinely tested). |
Tafasitamab captured on Protein A chip can bind Recombinant Human CD19 Protein, His Tag (Cat. No. 11880-H08W1) with an affinity constant of 5.088 nM as determined in an SPR assay (Biacore T200) (Routinely tested). |
Coltuximab captured on Protein A chip can bind Recombinant Human CD19 Protein, His Tag (Cat. No. 11880-H08W1) with an affinity constant of 3.310 nM as determined in an SPR assay (Biacore T200) (Routinely tested). |
Cancer Drug Targets
Zola H, et al. (2007) CD molecules 2006-human cell differentiation molecules. J Immunol Methods. 318 (1-2): 1-5.
Ho IC, et al. (2009) GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 9 (2): 125-35.
Matesanz-Isabel J, et al. (2011) New B-cell CD molecules. Immunology Letters.134 (2): 104-12.
Carter RH, et al. (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256 (5053): 105-7.
400-829-0116